SCHEMBL17876013

SCHEMBL17876013

O=S1(=O)Cc2ccc(-c3cc(-c4ccccc4)nc(-c4ccccc4)c3)cc2-c2cc(-c3cc(-c4ccccc4)nc(-c4ccccc4)c3)ccc2C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.43
KMT2A Q03164 6/20 0.43
CYP19A1 P11511 1/20 0.41
ALDH1A1 P00352 4/20 0.39
HPGD P15428 3/20 0.39
MAPT P10636 2/20 0.39
TYRO3 Q06418 1/20 0.39
NTRK2 Q16620 1/20 0.39
CLK4 Q9HAZ1 1/20 0.39
DYRK1B Q9Y463 1/20 0.39
MCL1 Q07820 2/20 0.38
KDM4E B2RXH2 2/20 0.37
LMNA P02545 2/20 0.37
HSP90AA1 P07900 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
CTRC Q99895 1/20 0.37
DHODH Q02127 1/20 0.37
ADORA1 P30542 2/20 0.36
ADORA3 P0DMS8 1/20 0.36
ADORA2B P29275 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17876011 0.97 CYP19A1 (0.43) MEN1KMT2ACYP19A1ALDH1A1HPGD
SCHEMBL17875977 0.94 MEN1 (0.39) MEN1KMT2ACYP19A1ALDH1A1HPGD
SCHEMBL17875961 0.92 CYP19A1 (0.39) MEN1KMT2ACYP19A1ALDH1A1HPGD
SCHEMBL17875975 0.92 CYP19A1 (0.39) MEN1KMT2ACYP19A1ALDH1A1HPGD
SCHEMBL17876014 0.89 CYP19A1 (0.56) CYP19A1KDM4EDHODH
SCHEMBL17876006 0.86 PLA2G2A (0.38) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL17875996 0.86 HCRTR1 (0.37) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL17876009 0.85 TYRO3 (0.47) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL17875974 0.85 CYP19A1 (0.51) CYP19A1KDM4EDHODH
SCHEMBL17875965 0.85 CYP19A1 (0.51) CYP19A1KDM4EDHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 MEN1 448/4885KMT2A 1757/4885CYP19A1 167/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 MEN1 448/4885KMT2A 1757/4885CYP19A1 167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.